Cavallo, Maria Caterina
Cavazza, Marianna
Bonifazi, Francesca http://orcid.org/0000-0003-1544-9911
Casadei, Beatrice
Cutini, Ilaria
Tonietti, Barbara
Saccardi, Riccardo
Zinzani, PierLuigi
Jommi, Claudio http://orcid.org/0000-0002-2862-2990
Funding for this research was provided by:
Gilead
Article History
Received: 19 April 2023
Accepted: 5 December 2023
First Online: 22 January 2024
Declarations
:
: Ethics will not require as no human an human data are involved in study.
: Not applicable.
: MCC has not conflicts of interest to declare. MC has not conflicts of interest to declare. FB participated to advisory boards and received speaker fees from Kyte-Gilead and Novartis, outside the submitted work. BC reported service as an advisory board member and a paid speaker for Abbvie, Beigene. IC has not conflicts of interest to declare. BT has not conflicts of interest to declare. RS reported serving as an advisory board member and a paid speaker for Kyte-Gilead, Sanofi, Novartis, Mallinkrot, Cytiva, Jazz Pharm, outside the submitted work. PLZ reported serving as an advisory board member and a paid speaker ADC Therapeutics, Astrazeneca, Beigene, BMS, Celltrion, Eusapharma, Gilead, Incyte, Janssen-Cilag, Kyowa Kirin, MSD, Novartis, Roche, Sandoz, Secura Bio, Servier, Takeda, outside the submitted work. CJ reported serving as an advisory board member and a paid speaker for Amgen, AstraZeneca, BMS, CSL Behring, Gilead, Incyte, MSD, Roche, Sanofi, Takeda, outside the submitted work.